CDKN2A and neoplasm: In contrast to other HGGs, deletions in CDKN2A/B, encoding the p16INK4A and p15INK4B tumour suppressors, are rare in DMGs; however, it has been shown that CDKN2A is epigenetically silenced due to the H3K27M mutation [106,203,204].